Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:business_executive
biologist |
| gptkbp:boardMemberOf |
gptkb:Centessa_Pharmaceuticals
gptkb:Passage_Bio gptkb:SpringWorks_Therapeutics gptkb:Arvinas |
| gptkbp:degree |
gptkb:PhD
|
| gptkbp:education |
gptkb:Wesleyan_University
|
| gptkbp:fieldOfStudy |
biochemistry
|
| gptkbp:formerPosition |
Executive Vice President at Alexion Pharmaceuticals
Chief Scientific Officer at Alexion Pharmaceuticals |
| gptkbp:founder |
gptkb:Alexion_Pharmaceuticals
|
| gptkbp:hasWorkedWith |
gptkb:BridgeBio_Pharma
gptkb:OrbiMed_Advisors gptkb:Regeneron_Pharmaceuticals gptkb:Alexion_Pharmaceuticals |
| https://www.w3.org/2000/01/rdf-schema#label |
Stephen Squinto
|
| gptkbp:knownFor |
biotechnology entrepreneurship
rare disease drug development |
| gptkbp:nationality |
gptkb:American
|
| gptkbp:occupation |
gptkb:business_executive
biologist |
| gptkbp:bfsParent |
gptkb:Blackstone_Life_Sciences
|
| gptkbp:bfsLayer |
6
|